Literature DB >> 26176360

Immunization of children with secondary immunodeficiency.

Susanna Esposito1, Elisabetta Prada1, Mara Lelii1, Luca Castellazzi1.   

Abstract

The main causes of secondary immunodeficiency at a pediatric age include infectious diseases (mainly HIV infection), malignancies, haematopoietic stem cell or solid organ transplantation and autoimmune diseases. Children with secondary immunodeficiency have an increased risk of severe infectious diseases that could be prevented by adequate vaccination coverage, but vaccines administration can be associated with reduced immune response and an increased risk of adverse reactions. The immunogenicity of inactivated and recombinant vaccines is comparable to that of healthy children at the moment of vaccination, but it undergoes a progressive decline over time, and in the absence of a booster, the patients remain at risk of developing vaccine-preventable infections. However, the administration of live attenuated viral vaccines is controversial because of the risk of the activation of vaccine viruses. A specific immunization program should be administered according to the clinical and immunological status of each of these conditions to ensure a sustained immune response without any risks to the patients' health.

Entities:  

Keywords:  HIV; autoimmune disease; cancer; immunosuppressive drugs; prevention; secondary immunodeficiency; transplantation; vaccination; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26176360      PMCID: PMC4685680          DOI: 10.1080/21645515.2015.1039208

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  63 in total

1.  Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection.

Authors:  Howard M Rosenblatt; Lin Y Song; Sharon A Nachman; Kenneth E Stanley; Paul A Krogstad; George M Johnson; Andrew A Wiznia
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

2.  Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine.

Authors:  Shahana A Choudhury; Fazle Matin
Journal:  Int J Infect Dis       Date:  2013-09-07       Impact factor: 3.623

3.  Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults.

Authors:  Vania Giacomet; Francesca Penagini; Daria Trabattoni; Alessandra Viganò; Veronica Rainone; Giada Bernazzani; Claudia Maria Bonardi; Mario Clerici; Giorgio Bedogni; Gian Vincenzo Zuccotti
Journal:  Vaccine       Date:  2014-08-20       Impact factor: 3.641

Review 4.  Biologics in children's autoimmune disorders: efficacy and safety.

Authors:  Luciana Breda; Marianna Del Torto; Sara De Sanctis; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2010-06-17       Impact factor: 3.183

5.  Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Authors:  Mark J Abzug; Stephen I Pelton; Lin-Ye Song; Terence Fenton; Myron J Levin; Sharon A Nachman; William Borkowsky; Howard M Rosenblatt; John F Marcinak; Arry Dieudonne; Elaine J Abrams; Indu Pathak
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

Review 6.  Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.

Authors:  William T Shearer; Thomas A Fleisher; Rebecca H Buckley; Zuhair Ballas; Mark Ballow; R Michael Blaese; Francisco A Bonilla; Mary Ellen Conley; Charlotte Cunningham-Rundles; Alexandra H Filipovich; Ramsay Fuleihan; Erwin W Gelfand; Vivian Hernandez-Trujillo; Steven M Holland; Richard Hong; Howard M Lederman; Harry L Malech; Stephen Miles; Luigi D Notarangelo; Hans D Ochs; Jordan S Orange; Jennifer M Puck; John M Routes; E Richard Stiehm; Kathleen Sullivan; Troy Torgerson; Jerry Winkelstein
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

7.  Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response.

Authors:  Marisa Zanchetta; Alessia Anselmi; Daniela Vendrame; Osvalda Rampon; Carlo Giaquinto; Antonio Mazza; Daniele Accapezzato; Vincenzo Barnaba; Anita De Rossi
Journal:  Antivir Ther       Date:  2008

Review 8.  Immune responsiveness and protective immunity after transplantation.

Authors:  Shivaprakash Gangappa; Kenneth E Kokko; Lisa M Carlson; Tania Gourley; Kenneth A Newell; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  Transpl Int       Date:  2008-01-21       Impact factor: 3.782

9.  Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence.

Authors:  K Davies; P Woo
Journal:  Rheumatology (Oxford)       Date:  2002-08       Impact factor: 7.580

10.  Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy.

Authors:  Susanna Esposito; Valerio Cecinati; Barbara Scicchitano; Giovanni Carlo Delvecchio; Nicola Santoro; Doriana Amato; Claudio Pelucchi; Momcilo Jankovic; Domenico De Mattia; Nicola Principi
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

View more
  5 in total

Review 1.  Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Authors:  Susanna Esposito; Paolo Bonanni; Stefania Maggi; Litjan Tan; Filippo Ansaldi; Pier Luigi Lopalco; Ron Dagan; Jean-Pierre Michel; Pierre van Damme; Jacques Gaillat; Roman Prymula; Timo Vesikari; Cristina Mussini; Uwe Frank; Albert Osterhaus; Lucia Pastore Celentano; Marta Rossi; Valentina Guercio; Gaetan Gavazzi
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

Review 2.  Vaccines in Children with Inflammatory Bowel Disease: Brief Review.

Authors:  Susanna Esposito; Giulia Antoniol; Marialuisa Labate; Lucrezia Passadore; Patrizia Alvisi; Valeria Daccò; Chiara Ghizzi; Carla Colombo; Nicola Principi
Journal:  Vaccines (Basel)       Date:  2021-05-11

3.  A Quality Improvement Initiative to Increase and Sustain Influenza Vaccination Rates in Pediatric Oncology and Stem Cell Transplant Patients.

Authors:  Chris I Wong; Amy L Billett; Shicheng Weng; Kelly Eng; Usha Thakrar; Kimberly J Davies
Journal:  Pediatr Qual Saf       Date:  2018-01-05

Review 4.  Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients?

Authors:  Emeline Vinkenes; Martine A Nielsen; Jan Blaakaer
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-04-20

Review 5.  Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review.

Authors:  Shannon E MacDonald; Airlie Palichuk; Linda Slater; Hailey Tripp; Laura Reifferscheid; Catherine Burton
Journal:  Hum Vaccin Immunother       Date:  2021-07-16       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.